Post-IPO Equity - Acer Therapeutics - Sep 19, 2017 Funding Round Profile - Cointime

Bitcoin $91,938.91 -2.20%
Ethereum $3,311.98 -3.56%
BNB $610.33 -4.92%
Optimism $2.17 -6.80%
Arbitrum $0.85 -4.65%
Solana $229.76 -2.88%
Polygon $0.52 -6.04%
Cosmos $7.86 -2.14%
Avalanche $42.23 +0.45%

Bitcoin $91,938.91 -2.20%
Ethereum $3,311.98 -3.56%
BNB $610.33 -4.92%
Optimism $2.17 -6.80%
Arbitrum $0.85 -4.65%
Solana $229.76 -2.88%
Polygon $0.52 -6.04%
Cosmos $7.86 -2.14%
Avalanche $42.23 +0.45%

Acer Therapeutics

company

Funding Round

Post-IPO Equity

Money Raised

$ 15.70M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
TVM Capital Life Science	-	Yes	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
May 6, 2016	Post-IPO Equity	$ 8.14M	TVM Capital Life Science	Detail
Apr 2, 2015	Post-IPO Debt	$ 2.10M		Detail